‘…acute psychotic reactions, generally lasting but a few hours, but occasionally as long as a week; the reaction seemed dose-related and its main features ...
No additional exclusions were applied by the investigators during screening. The patients were randomised (1:1:1) to receive either ranibizumab 0.5 mg T&E with laser (T&E+laser; n=121), ranibizumab ...
Expert Rev Neurother. 2010;10(7):1053-1088.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback